跳至主要内容
临床试验/DRKS00000195
DRKS00000195已完成未知

A randomized placebo-controlled trial about the effect of UVB-irradiated white button mushrooms (Agaricus bisporus) and a vitamin D2 supplement on the 25(OH)D levels in healthy adults.

Medizinische Universitätsklinik Freiburg - Abteilung Innere Medizin IHämatologie und Onkologie0 个研究点目标入组 24 人开始时间: 2009年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • healthy general condition based on medical history and examination at admission
  • - body mass index (BMI) between 18,5 and 26 kg/m²
  • - serum 25(OH)D < 25 ng/ml (< 50 nM)
  • - serum calcium in normal range 2,15 ? 2,55 mM
  • - written informed consent of the participants after educational advertising

排除标准

  • - anamnesis of kidney stone
  • - pregnancy
  • - white button mushrooms intolerance or allergy
  • - visit of a tanning salon right before or during the study
  • - eating fish or liver during the study
  • - taking supplements of Vitamin D during the study
  • - abidance in the mountains or southern countries during the study
  • - serum calcium > 5,2 mM during the study
  • - cancellation of the informed consent

研究者

发起方
Medizinische Universitätsklinik Freiburg - Abteilung Innere Medizin IHämatologie und Onkologie

相似试验

尚未招募
2 期
A randomized placebo-controlled trial of Vitamin-D supplementation in bronchiectasis
CTRI/2023/11/059393ICMR
招募中
4 期
The impact of Clonidine, a pharmacological treatment for attention deficit hyperactivity disorder (ADHD), on behavioural and brain imaging measures of attention, inhibition and error processing.Study employs a commonly used ADHD medication (Clonidine) with healthy human adults (only) and examines changes in behaviours that are of relevance to ADHD (inhibition, error processing, selective attention)Mental Health - Other mental health disorders
ACTRN12615000093583Professor Mark Bellgrove26
招募中
1 期
A study to assess the efficacy of a cardiac drug and a anti-inflammatory drug in patients with post-acute inflammatory heart disease due to COVID-19Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imagingMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10007650Term: Cardiovascular disorder NOSSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2022-001682-12-ATGoethe University Frankfurt280
进行中(未招募)
不适用
A randomised, placebo-controlled trial of the effect of pioglitazone on vascular endothelial function and novel biomarkers for macrovascular events in diabetics with established peripheral arterial disease - PAD and Pioglitazone StudyThe study involves patients with type 2 Diabetes and Peripheral Arterial Disease.The overall objective of the research proposal is to determine the occurrence of biomarkers that typify the metabolic syndrome in patients with peripheral vascular diseases.
EUCTR2007-001800-20-GBniversity of Dundee
进行中(未招募)
不适用
A randomised, placebo controlled trial of the efficacy of the addition of spironolactone to modern antihypertensive treatment regimes in patients with resistant hypertension.
EUCTR2006-004846-17-GBSheffield Teaching Hospitals NHS Foundation Trust